Algert Global’s Vera Therapeutics VERA Stock Holding History

Algert Global’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.96M	Buy	92,250 +55,940	+154%	+$2.08M	0.05%	620
2026 Q1	$1.46M	Sell	36,310 -28,558	-44%	-$1.23M	0.02%	779
2025 Q4	$3.28M	Sell	64,868 -228,520	-78%	-$8.12M	0.05%	576
2025 Q3	$8.53M	Buy	293,388 +39,235	+15%	+$907K	0.14%	232
2025 Q2	$5.99M	Buy	254,153 +184,143	+263%	+$4.14M	0.13%	275
2025 Q1	$1.68M	Buy	70,010 +31,460	+82%	+$1.01M	0.04%	649
2024 Q4	$1.63M	Buy	38,550 +15,386	+66%	+$681K	0.04%	672
2024 Q3	$1.02M	Buy	23,164 +5,910	+34%	+$224K	0.03%	744
2024 Q2	$624K	Buy	17,254 +4,834	+39%	+$192K	0.02%	828
2024 Q1	$536K	Buy	+12,420	New	+$443K	0.02%	757

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Algert Global's VERA Position: Q2 2026 in Review

Algert Global increased its Vera Therapeutics (VERA) stake by 154% in Q2 2026, buying an estimated $2.08M and bringing the position to 92,250 shares worth $3.96M. The position accounts for 0.05% of the portfolio, ranked #620.

Algert Global first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.53M in Q3 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Algert Global held 92,250 shares of Vera Therapeutics worth $3.96M as of Q2 2026.
Algert Global bought 55,940 Vera Therapeutics shares in Q2 2026, an estimated $2.08M.
Vera Therapeutics made up 0.05% of Algert Global's portfolio in Q2 2026, its #620 holding.
Algert Global first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
Algert Global's Vera Therapeutics position peaked at $8.53M in Q3 2025.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.